Search for: "TEVA PHARMACEUTICALS USA, INC." Results 361 - 380 of 482
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
N.J. Chief Judge Bartle: Amgen Patents Not Invalid after Bench Trial
28 Jan 2011, 11:38 am by Andrew Russell
Teva Pharmaceuticals USA, Inc., C.A. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
Obviousness Type Double Patenting Does Not Require Later-Issued Patent With Shorter Term to Abridge Term of Earlier-Granted Patent With Longer Term
12 Jan 2011, 6:55 am by The Docket Navigator
Teva Pharmaceuticals USA Inc., et. al., 1-08-cv-00464 (DED January 7, 2011, Order) (Bartle, C.J.) [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
U.S. Supreme Court Petitioned to Review Federal Circuit Patent Use Code Decision
28 Dec 2010, 10:58 am by FDABlog HPM
USA, Inc. v. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Apotex Cert Petition on 180-Day Exclusivity Forfeiture Decision is DOA, Says Teva in Opposition Brief
13 Dec 2010, 4:55 pm by FDABlog HPM
Karst –       Last Friday, Teva Pharmaceuticals USA, Inc. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Chief Judge Gregory M. Sleet: Markman Opinion
8 Nov 2010, 7:35 am by Karen E. Keller
Teva Pharmaceuticals USA, Inc., C.A. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
Geneva Pharmaceuticals haunts Sun Pharma case on double-patenting
3 Nov 2010, 5:10 am by Lawrence B. Ebert
Teva Pharmaceuticals USA, Inc., 518 F.3d 1353 (Fed. [read post]
IPBiz - http://ipbiz.blogspot.com/
Teva Pharmaceuticals USA, Inc. v. Eisai Co., Ltd. (Fed. Cir. 2010)
12 Oct 2010, 9:59 pm by Patent Docs
§ 2201) in the Hatch-Waxman context in Teva Pharmaceuticals USA, Inc. v. [read post]
Patent Docs - http://www.patentdocs.org/
Pharma & Biotech Global Week in Review 13 October 2010 from IP Think Tank
12 Oct 2010, 8:56 pm by Kelly
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Does a Subsequent Paragraph IV Filer Have a Legally Cognizable Interest in When a First-Filer’s 180-Day Exclusivity Period Begins for DJ Jurisdiction Purposes?
6 Oct 2010, 11:43 pm by FDABlog HPM
USA v. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Teva v. Eisai: Standing for subsequent Paragraph IV filers
6 Oct 2010, 4:31 pm by Jason Rantanen
By Jason RantanenTeva Pharmaceuticals USA, Inc. v. [read post]
Patently-O - http://www.patentlyo.com/patent/
Judge Bartle: Motion to Exclude Patent Law Expert GRANTED in Part
29 Sep 2010, 8:28 am by Karen E. Keller
Teva Pharmaceuticals USA, Inc., C.A. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
Pharma & Biotech Global Week in Review 29 September 2010 from IP Think Tank
28 Sep 2010, 3:14 pm by Kelly
Teva Pharmaceuticals USA Inc. et al. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
General Global Week in Review 27 September 2010 from IP Think Tank
26 Sep 2010, 10:08 pm by Marie Louise
Teva Pharmaceuticals USA Inc. et al (Docket Report) District Court N D Illinois: Draft opinion letter sinks induced infringement claim: Goss International Americas, Inc. v. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Examination Guidelines Update: Obviousness Examples from Federal Circuit Cases
24 Sep 2010, 1:15 pm by Stephen Albainy-Jenei
Teva Pharmaceuticals USA, Inc., 566 F.3d 989 (Fed. [read post]
Patent Baristas - http://www.patentbaristas.com
May a Patent Law Expert Opine as to the Materiality of Undisclosed Information?
23 Sep 2010, 12:02 pm by The Docket Navigator
Teva Pharmaceuticals USA Inc. et al., 1-08-cv-00464 (DED September 21, 2010 Memorandum) (Bartle, J.) [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Court Report
12 Sep 2010, 9:55 pm by Patent Docs
Teva Pharmaceutical Industries Ltd. et al. 1:10-cv-00766; filed September 8, 2010 in the District Court of Delaware • Plaintiffs: Abbott Laboratories; Abbott Respiratory LLC • Defendants: Teva Pharmaceutical Industries Ltd.; Teva Pharamceuticals USA, Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Pharma & Biotech Global Week in Review 8 September 2010 from IP Think Tank
7 Sep 2010, 6:10 pm by Kelly
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to Kirin… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Eli Lilly & Co. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2010)
6 Sep 2010, 9:48 pm by Patent Docs
Teva Pharmaceuticals USA, Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Bone Loss
4 Sep 2010, 8:29 pm
Teva Pharmaceuticals USA (CAFC 2010-1005, 1033) precedential Teva argued the Bone Loss Patents and Low Dose Patent were obvious. [read post]
Patent Prospector - http://www.patenthawk.com/blog/
USPTO Guidelines for Determining Obviousness
2 Sep 2010, 10:51 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc., 566 F.3d 989 (Fed. [read post]
Patently-O - http://www.patentlyo.com/patent/